Press Releases

Date	Title and Summary	Additional Formats
September 6, 2022	Vericel to Present at the Morgan Stanley Global Healthcare and H.C. Wainwright Global Investment Conferences	View HTML PDF Version
August 3, 2022	Vericel Reports Second Quarter 2022 Financial Results	View HTML PDF Version
July 21, 2022	Vericel Announces Publication of Positive Results from Retrospective Study by the Burn and Reconstructive Centers of America (BRCA) of Patients with Large Posterior Trunk Burns Treated with Epicel	View HTML PDF Version
July 20, 2022	Vericel to Report Second-Quarter 2022 Financial Results on August 3, 2022	View HTML PDF Version
May 4, 2022	Vericel Reports First Quarter 2022 Financial Results	View HTML PDF Version
April 20, 2022	Vericel to Report First-Quarter 2022 Financial Results on May 4, 2022	View HTML PDF Version
March 15, 2022	Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on March 22, 2022	View HTML PDF Version
March 1, 2022	Vericel to Present at the Cowen 42nd Annual Health Care Conference on March 9, 2022	View HTML PDF Version
February 24, 2022	Vericel Announces Appointment of Jonathan Siegal as Principal Accounting Officer	View HTML PDF Version
February 24, 2022	Vericel Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Full-Year 2022 Financial Guidance	View HTML PDF Version

Investor Relations